Pieter Stokkers - Concepedia

Author

Pieter Stokkers

Amsterdam UMC Location University of Amsterdam

Also Known As

D J de Jong, Jeroen M. Jansen, M K Vu, P C F Stokkers, P STOKKERS, P Stokkers, P. C. F. STOKKERS, P. C. F. Stokkers, P. C. Stokkers, P. C.F. Stokkers

198

Publications

14K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location University of Amsterdam University Medical Center Groningen University of Groningen Amsterdam UMC Location Vrije Universiteit Amsterdam University of Amsterdam

About

Pieter Stokkers is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, gastroenterology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	25	3.6K
2	Public Health	3	3	295
3	Allergy	3	3	297
4	Engineering	1	1	49
5	Social Sciences	1	1	25

Pieter Stokkers

Publications

Citations

H-Index

Page 1

	Year	Citations
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease Filip Baert, Liesbeth Moortgat, Gert Van Assche, Gastroenterology InflammationMucosal ImmunologyImmunologyGastroenterologyClinical Gastroenterology	2009	821
Genome-wide association identifies multiple ulcerative colitis susceptibility loci Dermot McGovern, Agnès Gardet, Leif Törkvist, Nature Genetics Genome-wide Association StudyGenome-wide Association IdentifiesImmunologyGenetic EpidemiologyUlcerative Colitis	2010	674
A Genomewide Analysis Provides Evidence for Novel Linkages in Inflammatory Bowel Disease in a Large European Cohort Jochen Hampe, Stefan Schreiber, Sarah H. Shaw, The American Journal of Human Genetics Genome-wide Association StudyChronic Inflammatory DiseasesMolecular EpidemiologyNovel LinkagesMedicine	1999	378
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis, The Lancet. Gastroenterology & hepatology Terminal IleitisGastroenterologyMulticentre TrialSurgeryClinical Gastroenterology	2017	334
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease William J. Sandborn, Subrata Ghosh, Julián Panés, Clinical Gastroenterology and Hepatology InflammationChronic Inflammatory DiseasesAnti-inflammatoryCrohn ’Gastrointestinal Pharmacology	2014	295
Genetic Analysis of Innate Immunity in Crohn's Disease and Ulcerative Colitis Identifies Two Susceptibility Loci Harboring CARD9 and IL18RAP Alexandra Zhernakova, Eleonora A. Festen, Lude Franke, The American Journal of Human Genetics InflammationGenetic AnalysisAllergyMucosal ImmunologyPathogenesis	2008	255
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci Espen Melum, André Franke, Christoph Schramm, Nature Genetics Disease EtiologyImmunologyGenetic EpidemiologyPathologyCholangiopathies	2010	252
Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions Frank J.C. van den Broek, Paul Fockens, S. van Eeden, Gut	2008	247
Linkage of Inflammatory Bowel Disease to Human Chromosome 6p Jochen Hampe, Sarah H. Shaw, Robert Saiz, The American Journal of Human Genetics InflammationHuman Chromosome 6PAutoimmune DiseaseDisease MechanismHistopathology	1999	228
High frequency of early colorectal cancer in inflammatory bowel disease Maurice Lutgens, Frank P. Vleggaar, M.E.I. Schipper, Gut	2008	224

Page 1